129 related articles for article (PubMed ID: 38633289)
1. Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [
Abdlkadir AS; Al-Adhami D; Alsyouf B; Alhouwari R; Al-Rasheed U; Jaber O; Mohamad I; Al-Ibraheem A
Nucl Med Mol Imaging; 2024 May; 58(3):147-149. PubMed ID: 38633289
[No Abstract] [Full Text] [Related]
2. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
[TBL] [Abstract][Full Text] [Related]
3. Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.
Jang HW; Choi JY; Lee JI; Kim HK; Shin HW; Shin JH; Kim SW; Chung JH
Endocr J; 2010; 57(12):1045-54. PubMed ID: 20978365
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.
Jiang J; Yang Z; Zhang Y; Xu X; Wang M; Hu S; Yao Z; Pan H; Zhang Y; Li D
Clin Imaging; 2014; 38(6):797-801. PubMed ID: 24973077
[TBL] [Abstract][Full Text] [Related]
5.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of PET/CT with
Romero-Lluch AR; Cuenca-Cuenca JI; Guerrero-Vázquez R; Martínez-Ortega AJ; Tirado-Hospital JL; Borrego-Dorado I; Navarro-González E
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2004-2013. PubMed ID: 28646462
[TBL] [Abstract][Full Text] [Related]
7. Detection of Solitary Axillary Lymph Node Metastases from Hürthle Cell Carcinoma of the Thyroid on
Prabhu M; Jain D; Gupta SD; Bal C; Kumar R
Nucl Med Mol Imaging; 2018 Oct; 52(5):389-393. PubMed ID: 30344789
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic values of ultrasound and (18)F-fluoro-2-deoxy-D-glucose-positron emission tomography/computerized tomography for patients with suspected thyroid carcinoma and lymph node metastasis].
Lai XJ; Zhang B; Jiang YX; Dai Q; Zhao RN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):393-7. PubMed ID: 23987485
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of
Saponjski J; Macut D; Saranovic DS; Radovic B; Artiko V
Radiol Oncol; 2020 Nov; 55(1):18-25. PubMed ID: 33885241
[TBL] [Abstract][Full Text] [Related]
10. The role of
Şahin OE; Uslu-Beşli L; Asa S; Sağer S; Sönmezoğlu K
Hell J Nucl Med; 2020; 23(3):321-329. PubMed ID: 33367304
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Hyperparathyroidism.
Mohd Rohani MF; Bujang NL; Rosdi AH; Amir Hassan SZ
Clin Nucl Med; 2024 Jan; 49(1):e19-e21. PubMed ID: 37883221
[TBL] [Abstract][Full Text] [Related]
12. "Hepatic Superscan" Revealed on 18 F-FDG PET Due to Drug-Induced Fulminant Hepatitis.
Qiu G; Shao F; Xie P
Clin Nucl Med; 2024 Jan; 49(1):101-103. PubMed ID: 37976529
[TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD
Eur J Surg Oncol; 2008 May; 34(5):581-6. PubMed ID: 17892923
[TBL] [Abstract][Full Text] [Related]
14. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Conry BG; Papathanasiou ND; Prakash V; Kayani I; Caplin M; Mahmood S; Bomanji JB
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):49-57. PubMed ID: 19662413
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract][Full Text] [Related]
16. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Kauhanen S; Schalin-Jäntti C; Seppänen M; Kajander S; Virtanen S; Schildt J; Lisinen I; Ahonen A; Heiskanen I; Väisänen M; Arola J; Korsoff P; Ebeling T; Sane T; Minn H; Välimäki MJ; Nuutila P
J Nucl Med; 2011 Dec; 52(12):1855-63. PubMed ID: 22052128
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
18. F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer.
Piciu D; Piciu A
Case Rep Endocrinol; 2014; 2014():741262. PubMed ID: 24711931
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Cohen R; Bihan H; des Guetz G; Wind P; Martin A
Ann Endocrinol (Paris); 2009 Dec; 70(6):468-72. PubMed ID: 19744643
[TBL] [Abstract][Full Text] [Related]
20. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
